South Texas Accelerated Research Therapeutics (START), LLC

San Antonio, Texas 78229

3 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumor, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Multiple Myeloma, NHL, Non-Hodgkins Lymphoma, PNET, Pancreatic Neuroendocrine Tumors, Solid Tumors, Unresectable Breast Carcinoma

Studies at this site

• A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
• A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer — Recruiting now
• Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors — Recruiting now
• Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma — Stopped early
• Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors — Stopped early